Targeting PSMA is expected to result in high in vitro and in vivo image quality and cellular uptake by tumor cells due to these internalization characteristics that lead to enhanced tumor uptake and retention (Jeitner et al., 2022). The gene discussed is FOLH1; the disease is neoplasm.